Medical Properties Trust Inc (MPW)’s debt-to-equity and long-term debt/equity ratios

As of close of business last night, Medical Properties Trust Inc’s stock clocked out at $4.19, up 0.24% from its previous closing price of $4.18. In other words, the price has increased by $+0.0100 from its previous closing price. On the day, 18929290 shares were traded. MPW stock price reached its highest trading level at $4.3212 during the session, while it also had its lowest trading level at $4.1500.

Ratios:

To gain a deeper understanding of MPW’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.04 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.96. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.27.

On January 30, 2024, Deutsche Bank started tracking the stock assigning a Sell rating and target price of $2.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MPW now has a Market Capitalization of 2.50B and an Enterprise Value of 12.48B. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.88 while its Price-to-Book (P/B) ratio in mrq is 0.33. Its current Enterprise Value per Revenue stands at 14.31 whereas that against EBITDA is 17.89.

Stock Price History:

Over the past 52 weeks, MPW has reached a high of $10.74, while it has fallen to a 52-week low of $2.92. The 50-Day Moving Average of the stock is 3.7660, while the 200-Day Moving Average is calculated to be 6.1172.

Shares Statistics:

It appears that MPW traded 23.03M shares on average per day over the past three months and 20.07M shares per day over the past ten days. A total of 598.99M shares are outstanding, with a floating share count of 588.68M. Insiders hold about 1.74% of the company’s shares, while institutions hold 73.50% stake in the company. Shares short for MPW as of Feb 15, 2024 were 197.33M with a Short Ratio of 8.57, compared to 164.89M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 32.94% and a Short% of Float of 45.87%.

Dividends & Splits

With its trailing 12-month dividend rate of 0.88, MPW has a forward annual dividend rate of 0.88. Against a Trailing Annual Dividend Yield of 21.05%, it implies a Forward Annual Dividend Yield of 21.00%. The stock’s 5-year Average Dividend Yield is 8.34.

Earnings Estimates

As of right now, 3 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.08 for the current quarter, with a high estimate of $0.12 and a low estimate of $0.04, while EPS last year was $0.05. The consensus estimate for the next quarter is $0.14, with high estimates of $0.16 and low estimates of $0.13.

Analysts are recommending an EPS of between $0.52 and $0.48 for the fiscal current year, implying an average EPS of $0.5. EPS for the following year is $0.54, with 3 analysts recommending between $0.57 and $0.5.

Revenue Estimates

In the current quarter, 4 analysts expect revenue to total $284.81M. It ranges from a high estimate of $300.7M to a low estimate of $257.85M. As of the current estimate, Medical Properties Trust Inc’s year-ago sales were $350.21M, an estimated decrease of -18.70% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $311.16M, a decrease of -7.80% over than the figure of -$18.70% in the same quarter last year. There is a high estimate of $344.6M for the next quarter, whereas the lowest estimate is $277.6M.

A total of 4 analysts have provided revenue estimates for MPW’s current fiscal year. The highest revenue estimate was $1.3B, while the lowest revenue estimate was $1.1B, resulting in an average revenue estimate of $1.2B. In the same quarter a year ago, actual revenue was $1.33B, down -9.60% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $1.18B in the next fiscal year. The high estimate is $1.33B and the low estimate is $1.03B. The average revenue growth estimate for next year is down -2.20% from the average revenue estimate for this year.

Most Popular

[the_ad id="945"]